Bayesian Capital Management’s NovaGold Resources NG Stock Holding History

Bayesian Capital Management’s Portfolio NG Stock Details NG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-27,200	Closed	-$201K	–	690
2020 Q1	$201K	Buy	+27,200	New	+$233K	0.04%	586
2019 Q3	–	Sell	-11,100	Closed	-$66K	–	629
2019 Q2	$66K	Buy	+11,100	New	+$47.4K	0.01%	465

Other funds holding NG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JNE Partners London, United Kingdom $244M AUM 15.73% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bayesian Capital Management's NG Position: Q2 2020 in Review

Bayesian Capital Management sold out of NovaGold Resources (NG) in Q2 2020, closing a stake of 27,200 shares — an estimated $201K sold.

Bayesian Capital Management first reported a position in NG in Q2 2019 and held it in 2 quarters. The position peaked at $201K in Q1 2020. 205 funds tracked by Wall St. Rank hold NG as of Q2 2020.

Bayesian Capital Management reported no remaining NovaGold Resources position as of Q2 2020 after selling out during the quarter.
Bayesian Capital Management sold 27,200 NovaGold Resources shares in Q2 2020, an estimated $201K.
Bayesian Capital Management first reported a position in NovaGold Resources in Q2 2019 and held it in 2 quarters.
Bayesian Capital Management's NovaGold Resources position peaked at $201K in Q1 2020.
205 funds tracked by Wall St. Rank held NovaGold Resources as of Q2 2020.

Based on Bayesian Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.